Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Finasteride blocks progesterone's effect on absence seizures in rats.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Valproate is a mood stabilizer for bipolar disorder but has side effects and risks, especially during pregnancy.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Women with PCOS have more emotional and body image issues than healthy women.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hair loss can be an early sign of HIV infection.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Omeprazole effectively treats severe acid reflux in children for short-term use, but long-term safety needs more research.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

To diagnose hair loss, use a systematic approach including history, exams, and tests.